Explore the latest issue of Blood Neoplasia: ashpublications.org/bloodneoplas... #BloodJournals #BloodNeoplasia #Hemesky
This press release highlights how patients with sickle cell disease in vaso-occlusive crisis are often under-triaged resulting in poor adherence to pain management guidelines. Read the study in Blood Advances here: ashpublications.org/bloodadvance... #SickleCellDisease #BloodJournals #Hematology
ICYMI: Blood Neoplasia and Blood VTH are now indexed in PubMed! Your research in hematologic malignancies or vascular biology, thrombosis, and hemostasis will now be more discoverable than ever. Submit today: buff.ly/OcEH3eB #PubMed #BloodJournals #Hematology
🔊Mutations in AMBRA1 aggravate β-thalassemia; targeting MYD88 mutations in lymphomas; air pollution and incident VTE risk
🎧https://buff.ly/ERwOymO #bloodjournals
🚨Latest Blood issue out now featuring:
Spotlight: variant BTK resistance mutations in CLL
Review: myeloid contributions to immunotherapy outcomes
buff.ly/TQNxDCx #bloodjournals
📣Congratulations to Blood Red Cell Iron's first published paper!
Itaconate promotes the differentiation of murine stress erythroid progenitors by increasing Nrf2 activity buff.ly/4bkzcUi #bloodjournals
🚨New issue of Blood out now featuring:
Review Series: 25 years of TKIs in CML
buff.ly/4khznE8 #bloodjournals
📣New Blood VTH issue out now featuring:
Disorders of platelet number and function: basic and translational
https://buff.ly/41aW980 #bloodjournals
🚨New issue of Blood Neoplasia out now featuring:
Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma https://buff.ly/3XiCcuL #bloodjournals
🚨New Blood Advances issue out now featuring Inside Blood Advances:
How donor age affects RBC deformability in storage
Testicular follicular lymphoma: let me count the ways
The transplant debate: defining innovation for sickle cell https://buff.ly/435x7JN #bloodjournals
Blood Global Hematology Editor-in-Chief, Dr. Jorge Cortes at the ASH booth at HOA Asia!
#bloodjournals
📣Blood Global Hematology is now open for submissions. Submit your research!
https://buff.ly/43pfZ2b #bloodjournals
📣Blood Global Hematology is now open for submissions. Submit your research!
https://buff.ly/43pfZ2b #bloodjournals
📣🚨 Blood Global Hematology has published their first article, Hydroxyurea to Decrease Stroke Risk in Children with Sickle Cell Anemia: A Systematic Review and Meta-analysis. https://buff.ly/3QwBUfO #bloodjournals
🩸New Blood issue out now featuring:
How I Treat: quantitative fibrinogen disorders
https://buff.ly/41bjOFr #bloodjournals
🚨 📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! https://buff.ly/4b4PFfl #bloodjournals
🎉Congratulations to the Blood Cover Art Contest winner, Alan G. Ramsay and co-authors!
https://buff.ly/4b4PFfl #bloodjournals
🩸New Blood issue out now featuring:
Review Series: mantle cell lymphoma
https://buff.ly/4ifo39V #bloodjournals
🚨 📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! https://buff.ly/4b4PFfl #bloodjournals
🚨 New Blood Advances issue out now featuring Inside Blood Advances:
IDCH: is it now determined?
PETAL: a global view or R/R T-/NK-lymphoma treatment reality
Caregiver signaling questions in sickle cell disease https://buff.ly/3WVVmq8 #bloodjournals
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4jxtgLH #bloodjournals
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4jxtgLH #bloodjournals
📣 Blood Journal new issue!
https://buff.ly/4hF3aVe #bloodjournals
📣 Blood Advances new issue!
https://buff.ly/4gpERJV #bloodjournals
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4hgy1rk #bloodjournals
🔊First-line zanubrutinib, obinutuzumab, and venetoclax in mantle cell lymphoma; hyperdiploidy in multiple myeloma; and pegcrisantaspase plus venetoclax in relapsed/refractory acute myeloid leukemia 🎧https://buff.ly/4hgy1rk #bloodjournals
🔊Bonus episode out now featuring Review Series on Globin Disorders. 🎧https://buff.ly/4ge4cH0 #BloodJournals
📣The 9th Annual Blood Cover Art Contest will recognize outstanding images in the advancement of science. 🎨Vote now! #BloodJournals #CoverArtContest https://buff.ly/429Iz6W
🚨🎨Calling all art lovers & science enthusiasts! 📣The 9th Annual Blood Cover Art Contest is here to recognize the images driving science forward! Vote now! 🧬🩸 #BloodJournals #CoverArtContest https://buff.ly/3Wfn8xh
📣 Top 10 most read articles of the year published in Blood Advances! 🏆
https://buff.ly/3ZRqPun
#BloodJournals